Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2012 (2012), Article ID 654617, 3 pages
http://dx.doi.org/10.1155/2012/654617
Case Report

Metastatic Renal Cell Carcinoma Change Vascularity

Department of Urology, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-0042, Japan

Received 21 July 2012; Accepted 8 August 2012

Academic Editors: T. Nomura and F. M. Solivetti

Copyright © 2012 Takeshi Azuma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Porta, G. Tortora, C. Linassier et al., “Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement,” Medical Oncology, vol. 29, no. 3, pp. 1896–1907, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Motzer, M. D. Michaelson, B. G. Redman et al., “Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma,” Journal of Clinical Oncology, vol. 24, no. 1, pp. 16–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. B. Atkins, M. Hidalgo, W. M. Stadler et al., “Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma,” Journal of Clinical Oncology, vol. 22, no. 5, pp. 909–918, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Roca, A. Quivy, M. Gross-Goupil, J. C. Bernhard, H. De Clermont, and A. Ravaud, “Efficacy of re-challenging metastatic renal cell carcinoma with mtor inhibitors,” Acta Oncologica, vol. 50, pp. 1135–1136.
  5. I. N. Zama, T. E. Hutson, P. Elson et al., “Sunitinib rechallenge in metastatic renal cell carcinoma patients,” Cancer, vol. 116, no. 23, pp. 5400–5406, 2010. View at Publisher · View at Google Scholar · View at Scopus